Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Receivables - Net: 2021-2025

Historic Receivables - Net for Core Scientific (CORZ) over the last 3 years, with Mar 2025 value amounting to $1.0 million.

  • Core Scientific's Receivables - Net fell 8.04% to $1.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.0 million, marking a year-over-year decrease of 8.04%. This contributed to the annual value of $1.0 million for FY2024, which is 2.40% up from last year.
  • Latest data reveals that Core Scientific reported Receivables - Net of $1.0 million as of Q1 2025, which was down 0.68% from $1.0 million recorded in Q4 2024.
  • Core Scientific's 5-year Receivables - Net high stood at $6.2 million for Q3 2024, and its period low was $168,000 during Q1 2022.
  • For the 3-year period, Core Scientific's Receivables - Net averaged around $2.0 million, with its median value being $1.1 million (2024).
  • Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 83.07% in 2022, then skyrocketed by 539.88% in 2024.
  • Core Scientific's Receivables - Net (Quarterly) stood at $1.4 million in 2021, then crashed by 83.07% to $234,000 in 2022, then skyrocketed by 327.78% to $1.0 million in 2023, then climbed by 2.40% to $1.0 million in 2024, then decreased by 8.04% to $1.0 million in 2025.
  • Its Receivables - Net stands at $1.0 million for Q1 2025, versus $1.0 million for Q4 2024 and $6.2 million for Q3 2024.